Association between liver enzymes and metabolic syndrome: a study in Bangladeshi adults

References

• Dekker JM, Girman C, Rhodes T, et al. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation. 2005;112(5):666–673. doi: 10.1161/CIRCULATIONAHA.104.516948
   PubMed Web of Science ®Google Scholar
• Li X, Li X, Lin H, et al. Metabolic syndrome and stroke: a meta-analysis of prospective cohort studies. J Clin Neurosci. 2017;40:34–38. doi: 10.1016/j.jocn.2017.01.018
   PubMed Web of Science ®Google Scholar
• Ruderman NB, Carling D, Prentki M, et al. AMPK, insulin resistance, and the metabolic syndrome. J Clin Invest. 2013;123(7):2764–2772. doi: 10.1172/JCI67227
   PubMed Web of Science ®Google Scholar
• Xu S, Gao B, Xing Y, et al. Gender differences in the prevalence and development of metabolic syndrome in Chinese population with abdominal obesity. PLoS One. 2013;8(10):e78270. doi: 10.1371/journal.pone.0078270
   PubMed Web of Science ®Google Scholar
• Zhang Q, Lou S, Meng Z, et al. Gender and age impacts on the correlations between hyperuricemia and metabolic syndrome in Chinese. Clin Rheumatol. 2011;30(6):777–787. doi: 10.1007/s10067-010-1660-7
   PubMed Web of Science ®Google Scholar
• Ali N, Miah R, Hasan M, et al. Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults. Sci Rep. 2020;10(1):1–7. doi: 10.1038/s41598-020-64884-7
   PubMed Web of Science ®Google Scholar
• Chowdhury MZI, Anik AM, Farhana Z, et al. Prevalence of metabolic syndrome in Bangladesh: a systematic review and meta-analysis of the studies. BMC Public Health. 2018;18(1):1–14. doi: 10.1186/s12889-018-5209-z
   Google Scholar
• Sattar N, Forrest E, Preiss D. Non-alcoholic fatty liver disease. BMJ. 2014;349(sep19 15):g4596–g4596. doi: 10.1136/bmj.g4596
   PubMed Web of Science ®Google Scholar
• Nikniaz L, Nikniaz Z, Tabrizi JS, et al. Is within-normal range liver enzymes associated with metabolic syndrome in adults? Clin Res Hepatol Gastroenterol. Clin Res Hepatol Gastroenterol. 2018;42(1):92–98. doi: 10.1016/j.clinre.2017.06.006
   PubMed Web of Science ®Google Scholar
• Chitturi S, Farrell GC, George J. Non-alcoholic steatohepatitis in the Asia–pacific region: future shock? J Gastroenterol Hepatol. 2004;19(4):368–374. doi: 10.1111/j.1440-1746.2003.03252.x
   PubMed Web of Science ®Google Scholar
• Haffner SM. Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns. Am J Med. 2006;119(5):S3–S9. doi: 10.1016/j.amjmed.2006.01.008
   PubMed Web of Science ®Google Scholar
• Marchesini G, Marzocchi R, Agostini F, et al. Nonalcoholic fatty liver disease and the metabolic syndrome. Curr Opin Lipidol. 2005;16(4):421–427. doi: 10.1097/01.mol.0000174153.53683.f2
   PubMed Web of Science ®Google Scholar
• Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia. 2009;13:9.
   PubMed Web of Science ®Google Scholar
• Neuman MG, Cohen LB, Nanau RM. Biomarkers in nonalcoholic fatty liver disease. Can J Gastroenterol Hepatol. 2014;28(11):607–618. doi: 10.1155/2014/757929
   PubMed Web of Science ®Google Scholar
• Abenavoli L, Scarlata GGM, Scarpellini E, et al. Metabolic-dysfunction-associated fatty liver disease and gut microbiota: from fatty liver to dysmetabolic syndrome. Med Kaunas Lith. 2023;59(3):594. doi: 10.3390/medicina59030594
   PubMed Web of Science ®Google Scholar
• Goessling W, Massaro JM, Vasan RS, et al. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology. 2008;135(6):1935–1944.e1. doi: 10.1053/j.gastro.2008.09.018
   PubMed Web of Science ®Google Scholar
• Seppälä-Lindroos A, Vehkavaara S, Häkkinen A-M, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab. 2002;87(7):3023–3028. doi: 10.1210/jcem.87.7.8638
   PubMed Web of Science ®Google Scholar
• Wannamethee SG, Shaper AG, Lennon L, et al. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care. 2005;28(12):2913–2918. doi: 10.2337/diacare.28.12.2913
   PubMed Web of Science ®Google Scholar
• Ali N, Sumon AH, Fariha KA, et al. Assessment of the relationship of serum liver enzymes activity with general and abdominal obesity in an urban Bangladeshi population. Sci Rep. 2021;11(1):1–9. doi: 10.1038/s41598-021-86216-z
   PubMed Web of Science ®Google Scholar
• Islam S, Rahman S, Haque T, et al. Prevalence of elevated liver enzymes and its association with type 2 diabetes: a cross-sectional study in Bangladeshi adults. Endocrinol Diabetes Metab. 2020;3(2):e00116. doi: 10.1002/edm2.116
   PubMedGoogle Scholar
• Kathak RR, Sumon AH, Molla NH, et al. The association between elevated lipid profile and liver enzymes: a study on Bangladeshi adults. Sci Rep. 2022;12(1):1–8. doi: 10.1038/s41598-022-05766-y
   PubMed Web of Science ®Google Scholar
• Kawamoto R, Kohara K, Tabara Y, et al. Serum gamma-glutamyl transferase levels are associated with metabolic syndrome in community-dwelling individuals. J Atheroscler Thromb. 2009;16(4):355–362. doi: 10.5551/jat.No414
   PubMed Web of Science ®Google Scholar
• Kim HR, Han MA. Association between serum liver enzymes and metabolic syndrome in Korean adults. Int J Environ Res Public Health. 2018;15(8):1658. doi: 10.3390/ijerph15081658
   PubMed Web of Science ®Google Scholar
• Perera S, Lohsoonthorn V, Jiamjarasrangsi W, et al. Association between elevated liver enzymes and metabolic syndrome among Thai adults. Diabetes Metab Syndr Clin Res Rev. 2008;2(3):171–178. doi: 10.1016/j.dsx.2008.04.012
   PubMedGoogle Scholar
• Rahman S, Islam S, Haque T, et al. Association between serum liver enzymes and hypertension: a cross-sectional study in Bangladeshi adults. BMC Cardiovasc Disord. 2020;20(1):1–7. doi: 10.1186/s12872-020-01411-6
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang J, Zhu L, et al. Association between liver function and metabolic syndrome in Chinese men and women. Sci Rep. 2017;7(1):44844. doi: 10.1038/srep44844
   PubMedGoogle Scholar
• Zhang L, Ma X, Jiang Z, et al. Liver enzymes and metabolic syndrome: a large-scale case-control study. Oncotarget. 2015;6(29):26782. doi: 10.18632/oncotarget.5792
   PubMedGoogle Scholar
• Nannipieri M, Gonzales C, Baldi S, et al. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico city diabetes study. Diabetes Care. 2005;28(7):1757–1762. doi: 10.2337/diacare.28.7.1757
   PubMed Web of Science ®Google Scholar
• Ishizaka N, Ishizaka Y, Toda E-I, et al. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005;25(5):1038–1044. doi: 10.1161/01.ATV.0000161274.87407.26
   PubMed Web of Science ®Google Scholar
• Ali N, Mahmood S, Islam F, et al. Relationship between serum uric acid and hypertension: a cross-sectional study in Bangladeshi adults. Sci Rep. 2019;9(1):1–7. doi: 10.1038/s41598-019-45680-4
   PubMed Web of Science ®Google Scholar
• Ali N, Mahmood S, Manirujjaman M, et al. Hypertension prevalence and influence of basal metabolic rate on blood pressure among adult students in Bangladesh. BMC Public Health. 2018;18(1):1–9. doi: 10.1186/s12889-017-4617-9
   Google Scholar
• Haque T, Rahman S, Islam S, et al. Assessment of the relationship between serum uric acid and glucose levels in healthy, prediabetic and diabetic individuals. Diabetol Metab Syndr. 2019;11(1):1–8. doi: 10.1186/s13098-019-0446-6
   PubMedGoogle Scholar
• Molla NH, Kathak RR, Sumon AH, et al. Assessment of the relationship between serum uric acid levels and liver enzymes activity in Bangladeshi adults. Sci Rep. 2021;11(1):1–9. doi: 10.1038/s41598-021-99623-z
   PubMed Web of Science ®Google Scholar
• Mou AD, Barman Z, Hasan M, et al. Prevalence of preeclampsia and the associated risk factors among pregnant women in Bangladesh. Sci Rep. 2021;11(1):1–9. doi: 10.1038/s41598-021-00839-w
   PubMed Web of Science ®Google Scholar
• Saadi MM, Roy MN, Haque R, et al. Association of microalbuminuria with metabolic syndrome: a cross-sectional study in Bangladesh. BMC Endocr Disord. 2020;20(1):1–7. doi: 10.1186/s12902-020-00634-0
   PubMed Web of Science ®Google Scholar
• Ali N, Samadder M, Kathak RR, et al. Prevalence and factors associated with dyslipidemia in Bangladeshi adults. PLoS One. 2023;18(1):e0280672. doi: 10.1371/journal.pone.0280672
   PubMed Web of Science ®Google Scholar
• Ali N, Mahmud F, Akter SA, et al. The prevalence of general obesity, abdominal obesity, and hypertension and its related risk factors among young adult students in Bangladesh. J Clin Hypertens Greenwich Conn. 2022;24(10):1339–1349. doi: 10.1111/jch.14560
   PubMed Web of Science ®Google Scholar
• Ali N, Mohanto NC, Nurunnabi SM, et al. Prevalence and risk factors of general and abdominal obesity and hypertension in rural and urban residents in Bangladesh: a cross-sectional study. BMC Public Health. 2022;22(1):1707. doi: 10.1186/s12889-022-14087-8
   PubMed Web of Science ®Google Scholar
• Ali N, Rahman S, Islam S, et al. The relationship between serum uric acid and lipid profile in Bangladeshi adults. BMC Cardiovasc Disord. 2019;19(1):1–7. doi: 10.1186/s12872-019-1026-2
   PubMedGoogle Scholar
• Ali N, Perveen R, Rahman S, et al. Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: a study on Bangladeshi adults. PLoS One. 2018;13(11):e0206850. doi: 10.1371/journal.pone.0206850
   PubMed Web of Science ®Google Scholar
• Barman Z, Hasan M, Miah R, et al. Association between hyperuricemia and chronic kidney disease: a cross-sectional study in Bangladeshi adults. BMC Endocr Disord. 2023;23(1):45. doi: 10.1186/s12902-023-01304-7
   PubMed Web of Science ®Google Scholar
• Hasan M, Fariha KA, Barman Z, et al. Assessment of the relationship between serum xanthine oxidase levels and type 2 diabetes: a cross-sectional study. Sci Rep. 2022;12(1):20816. doi: 10.1038/s41598-022-25413-w
   PubMed Web of Science ®Google Scholar
• Miah R, Fariha KA, Sony SA, et al. Association of serum xanthine oxidase levels with hypertension: a study on Bangladeshi adults. Sci Rep. 2022;12(1):21727. doi: 10.1038/s41598-022-26341-5
   PubMed Web of Science ®Google Scholar
• Cleeman JI, Grundy SM, Becker D, et al. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National cholesterol Education Program (NCEP) adult treatment panel (ATP III). JAMA. 2001;285(19):2486–2497. doi: 10.1001/jama.285.19.2486
   PubMed Web of Science ®Google Scholar
• Schumann G, Klauke R. New IFCC reference procedures for the determination of catalytic activity concentrations of five enzymes in serum: preliminary upper reference limits obtained in hospitalized subjects. Clin Chim Acta. 2003;327(1–2):69–79. doi: 10.1016/S0009-8981(02)00341-8
   PubMed Web of Science ®Google Scholar
• Tietz NW, Shuey DF. Reference intervals for alkaline phosphatase activity determined by the IFCC and AACC reference methods. Clin Chem. 1986;32(8):1593–1594. doi: 10.1093/clinchem/32.8.1593a
   PubMed Web of Science ®Google Scholar
• Steinvil A, Shapira I, Ben-Bassat OK, et al. The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome. Cardiovasc Diabetol. 2010;9(1):1–11. doi: 10.1186/1475-2840-9-30
   PubMedGoogle Scholar
• Xia M-F, Yan H-M, Lin H-D, et al. Elevation of liver enzymes within the normal limits and metabolic syndrome. Clin Exp Pharmacol Physiol. 2011;38(6):373–379. doi: 10.1111/j.1440-1681.2011.05519.x
   PubMed Web of Science ®Google Scholar
• Rantala AO, Lilja M, Kauma H, et al. Gamma-glutamyl transpeptidase and the metabolic syndrome. J Intern Med. 2000;248(3):230–238. doi: 10.1046/j.1365-2796.2000.00723.x
   PubMed Web of Science ®Google Scholar
• Nakanishi N, Suzuki K, Tatara K. Serum γ-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2004;27(6):1427–1432. doi: 10.2337/diacare.27.6.1427
   PubMed Web of Science ®Google Scholar
• Hanley AJ, Williams K, Festa A, et al. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes. 2005;54(11):3140–3147. doi: 10.2337/diabetes.54.11.3140
   PubMed Web of Science ®Google Scholar
• Patel DA, Srinivasan SR, Xu J-H, et al. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism. 2007;56(6):792–798. doi: 10.1016/j.metabol.2007.01.010
   PubMed Web of Science ®Google Scholar